In vivo Evaluation of Tazarotene Solid Lipid Nanoparticles Gel For Topical Delivery
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2019, Vol 11, Issue 1
Abstract
The purpose of this research work was to develop and optimize the Solid Lipid Nanoparticles (SLNs) of Tazarotene for the effective topical delivery in the treatment of psoriasis. Tazarotene loaded SLNs were prepared by hot homogenization followed by the ultrasonication using Taguchi’s design and based on the results further investigation was made using central composite design. The lipid Dynasan-116, surfactant poloxomer-188 and co surfactant egg lecithin resulted in better percent drug loading and evaluated for particle size, zeta potential, TEM, drug entrapment efficiency, in vitro drug release and stability. All parameters were found to be in an acceptable range. In vitro drug release of optimized SLN formulation (F1) was found to be 98.12 ± 1.52%, whereas pure drug release was 42.12 after 60 min. The optimized formulation was incorporated into the gel. The release rate (flux) of tazarotene across the membrane and excised skin differs significantly. The accumulative amount of Tazarotene in skin from SLN based gel formulation and marketed gel were 41.12 ± 0.12 mg and 30.02 ± 0.04 mg respectively. This result supported our hypothesis made in skin permeation studies on rat skin. From histopathological studies the microscopic observations indicate that the optimized SLN formulation, SLN based gel formulation and marketed gel has no significant effect on the microscopic structure of the skin. The skin-irritation studies indicated that SLN based gel containing Tazarotene did not show any sign of skin irritation as compared to moderate erythema shown by marketed gel formulation (Tazret® gel) after 72 h of application. Thus, SLN based gel formulation demonstrated advantage over marketed formulation in improving the skin tolerability of Tazarotene indicating their potential in improving patient acceptance and topical delivery of Tazarotene.
Authors and Affiliations
Rajkumar Aland, M. Ganesan, P. Rajeswara Rao
Keywords
Related Articles
- EP ID EP446016
- DOI 10.25004/IJPSDR.2019.110107
- Views 122
- Downloads 0
Antioxidant and antimicrobial activity of different plant parts of Anacardium occidentale L. and Mangifera indica L.: a comparative study
Anacardium occidentale L. and Mangifera indica L. has been used worldwide both for pharmaceutical, food and cosmetic industries due to the presence of biological activities of some of its metabolites. The present study c...
STANDARDIZATION OF CHITRAKADI VATI: AN AYURVEDIC POLYHERBAL FORMULATION
Standardization of herbal formulation is essential in order to assess the quality, purity, safety and efficacy of drugs. World health organization (WHO) in 1999 has given a detail protocol for the standardization of herb...
PHARMACOKINETIC INTERACTIONS BETWEEN CONCOMITANTLY ADMINISTERED PHENYTOIN WITH RIVAROXABAN
In the present investigation it was aimed to evaluate any possible pharmacokinetic interactions between Phenytoin and Rivaroxaban. Study was conducted in Male Wistar rats; animals were divided into three groups. Group 1...
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE USING PLANTAGO OVATA (ISAPGHULA) MUCILAGE AS NATURAL SUPER DISINTEGRATING AGENT
Mouth dissolving tablet is an innovative solid unit dosage form that overcome the problem of swallowing and provide rapid disintegration & dissolution to release the drug as soon as they come in contact with saliva,...
THERAPEUTIC L-ASPARAGINASE ACTIVITY OF BACTERIA ISOLATED FROM MARINE SEDIMENTS
L-Asparaginase, a therapeutic enzyme used in lymphoblastic leukemia and lymphosarcoma chemotherapy which is derived mostly from the bacterial sources Escherichia coli and Erwinia sp. The long term administration of the d...